|
| Exchange Disseminated Time 28/03/2016 12:59:16 | Omkar Speciality Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 28, 2016, has transacted the following business:
1. Unanimously approved Scheme of Arrangement ("Scheme") between Omkar Speciality Chemicals Limited, Lasa Laboratory Private Limited, Urdhwa Chemicals Company Private Limited, Rishichem Research Limited, Desh Chemicals Private Limited and Lasa Supergenerics Limited for:
a) The merger of Lasa Laboratory Private Limited, Urdhwa Chemicals Company Private Limited, Rishichem Research Limited, Desh Chemicals Private Limited with Omkar Speciality Chemicals Limited; and
b) The demerger of the Veterinary API Undertaking of Merged Omkar Speciality Chemicals Limited into Lasa Supergenerics Limited;
2. Took on record Valuation Report submitted by M/s J.P.J. Associates (Chartered Accountants);
3. Took on record the Fairness Opinion on the Valuation Report of Saffron Capital Advisors Private Limited by March 28, 2016. |
|
|